|1.||Rittig, Søren: 8 articles (11/2015 - 07/2002)|
|2.||Christensen, Jane H: 7 articles (06/2013 - 01/2003)|
|3.||Gregersen, Niels: 7 articles (06/2013 - 07/2002)|
|4.||De Bellis, Annamaria: 6 articles (12/2015 - 04/2003)|
|5.||Maghnie, Mohamad: 6 articles (04/2015 - 01/2003)|
|6.||Siggaard, Charlotte: 6 articles (08/2005 - 07/2002)|
|7.||Robertson, Gary L: 6 articles (08/2005 - 05/2002)|
|8.||Alharfi, Ibrahim M: 5 articles (06/2015 - 02/2013)|
|9.||Stewart, Tanya Charyk: 5 articles (06/2015 - 02/2013)|
|10.||Fraser, Douglas D: 5 articles (06/2015 - 02/2013)|
|1.||Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
07/01/2006 - "We conclude that DDAVP administered subcutaneously can be a safe and effective alternative to traditionally recommended treatments of central diabetes insipidus during infancy."
10/01/1992 - "In our opinion the oral DDAVP is an effective and safe solution for the treatment of Central Diabetes Insipidus, and give to the patients a better quality of life in comparison to the nasal solution."
11/01/1997 - "To assess the efficacy of treatment with oral desmopressin (DDAVP), 20 patients, aged 5-20 y, with central diabetes insipidus were studied during 3 d of hospitalization and for 3 months at the outpatient clinic. "
03/01/1978 - "Improved psychological status of children under DDAVP therapy for central diabetes insipidus."
01/01/2013 - "Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study."
07/01/1991 - "The Authors have done a clinical study on the efficacy of desmopressin (DDAVP) tablets in the treatment of central diabetes insipidus in 13 patients who were previously treated with intranasal DDAVP. "
01/01/2013 - "Comments on "Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study"--efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus."
10/01/1992 - "In our study 3 patients with Central Diabetes Insipidus (aged 22-56; 2 idiopathic and 1 post-surgery) previously treated with DDAVP nasal solution (10 micrograms/day; 36-156 months), have been submitted to a chronic treatment with DDAVP tablets for a period of 24-36 months. "
03/01/1986 - "Seven paediatric patients with central diabetes insipidus were studied in an open dose ranging study in hospital followed by a six month study on an outpatient basis to assess the efficacy and safety of peroral administration of DDAVP (desmopressin) tablets. "
08/01/2003 - "We studied the efficacy and safety of oral 1-deamino-8-D-arginine-vasopressin (DDAVP) tablets in 9 patients, aged 17-36 years, with central diabetes insipidus (DI). "
02/01/2014 - "These animals manifest central diabetes insipidus (lack of circulating vasopressin) due to a mutation in the vasopressin-neurophysin gene. "
09/01/2013 - "Although pro-vasopressin is not a known physiological substrate of PCSK1, the development of central diabetes insipidus in this proband suggests that PCSK1 deficiency can be associated with impaired osmoregulation. "
04/01/2013 - "Combined water deprivation and vasopressin test revealed the diagnosis of central diabetes insipidus. "
04/01/2012 - "Autosomal dominant central diabetes insipidus is secondary to the toxic accumulation of vasopressin mutants as fibrillar aggregates in the endoplasmic reticulum of hypothalamic magnocellular neurons producing vasopressin. "
01/01/2012 - "Central diabetes insipidus which had become apparent had been treated with 1-desamino-8-D-arginine vasopressin. "
|4.||Arginine Vasopressin (Argipressin)IBA
12/01/1984 - "We eliminated the possibility of central diabetes insipidus (DI) and primary polydipsia, and established the presence of nephrogenic DI on the basis of: 1) the interrelationships between plasma osmolality, urine osmolality, and urinary AVP; and 2) impaired antidiuretic responses to AVP and 1 deamino-8-D-arginine vasopressin. "
12/01/2014 - "Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a mutation in the arginine-vasopressin II gene in four generations of a Korean family."
01/01/2013 - "Familial neurohypophyseal diabetes insipidus (FNDI) typically presents with age-dependent penetrance and autosomal dominant inheritance caused by missense variations in one allele of the AVP gene encoding the arginine vasopressin (AVP) prohormone. "
12/01/2008 - "Familial neurohypophyseal diabetes insipidus (FNDI) is a rare disorder resulting from arginine vasopressin (AVP) gene mutations. "
11/01/2008 - "Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel mutation in arginine-vasopressin gene in a Brazilian family."
04/01/2008 - "A water deprivation test and a low serum antidiuretic hormone level helped to confirm a diagnosis of central diabetes insipidus. "
04/01/2014 - "Neurogenic diabetes insipidus (DI) is a condition where the patient excretes large volume of dilute urine due to low levels of antidiuretic hormone. "
02/01/2013 - "Failure to concentrate urine during the water deprivation test followed by an increase in urine specific gravity after administration of synthetic antidiuretic hormone (ADH) suggested a diagnosis of central diabetes insipidus. "
11/14/2012 - "Central diabetes insipidus (CDI) is caused by deficient secretion of antidiuretic hormone (ADH) due to different conditions that can affect the hypothalamic neurons. "
04/01/2012 - "After intravenous and intrathecal administration of metotrexate, the patient developed signs of central diabetes insipidus, which responded to therapy with an antidiuretic hormone analog. "
|6.||Alendronate (Alendronate Sodium)FDA LinkGeneric
07/01/1999 - "In conclusion, this study demonstrated that a 6-month treatment with alendronate in patients with central diabetes insipidus was effective in significantly improving BMD at the lumbar spine, which was significantly worsened in untreated patients. "
07/01/1999 - "The aim of this open prospective randomized study was to evaluate the effect of a 6-month treatment with alendronate on the bone mineral density (BMD) at lumbar spine in patients with central diabetes insipidus. "
07/01/1999 - "Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus."
07/01/1999 - "Therefore, alendronate treatment could be used in patients with central diabetes insipidus with documented osteopenia or osteoporosis."
09/27/1999 - "Efficacy of indapamide in central diabetes insipidus."
10/01/1994 - "To investigate antidiuretic effect of indapamide, ten patients with central diabetes insipidus (CDI) were observed with the treatment of 2.5-7.5 mg of indapamide per day. "
10/01/1994 - "[Clinical trial of indapamide in the management of central diabetes insipidus]."
12/01/1990 - "To our knowledge, the antidiuretic effect of indapamide in central diabetes insipidus has not been reported previously."
12/01/1990 - "Indapamide produced a significant decrease in urinary output in three patients with central diabetes insipidus. "
|8.||Hydrochlorothiazide (Esidrix)FDA LinkGeneric
01/01/2014 - "Efficacy of Hydrochlorothiazide and low renal solute feed in Neonatal Central Diabetes Insipidus with transition to Oral Desmopressin in early infancy."
05/01/1985 - "[Comparative study of 1-deamino-8-D-arginine vasopressin, hydrochlorothiazide and chlorpropamide in the treatment of central diabetes insipidus]."
|9.||antineoplaston A10 (A 10)IBA
10/01/1994 - "Although the pathological basis of the posterior pituitary gland involvement was not ascertained, the temporal association of bronchocentric granulomatosis and central diabetes insipidus, as well as the fact that corticosteroid treatment provided stable remission of both conditions after a 10 month follow-up, strongly suggest that central diabetes insipidus was aetiologically related to bronchocentric granulomatosis in this patient."
|10.||Adrenocorticotropic Hormone (ACTH)FDA Link
08/01/2006 - "The hypophysitis presenting with central diabetes insipidus caused isolated adrenocorticotropic hormone (ACTH) deficiency after three years and two months since the onset of his illness. "
12/01/2001 - "To clarify the mechanism for the potentiation of CRH-induced ACTH response by the infusion of hypertonic saline, we investigated changes in plasma ACTH concentration after infusion of 5% hypertonic saline in five patients with untreated central diabetes insipidus (DI). "
06/01/2013 - "Precocious puberty and central diabetes insipidus (DI) was identified in two cases, respectively, and ACTH deficiency was found in one. "
07/01/1998 - "Central diabetes insipidus and Cushing's syndrome due to ectopic ACTH production by disseminated small cell lung cancer: a case report."
11/01/2006 - "We describe a newborn with congenital toxoplasmosis who presented with fever due to hypothalamo-pituitary dysregulation and combined hypothalamo-pituitary deficiencies consisting of central diabetes insipidus, hypothyroidism and ACTH deficiency."
05/01/1996 - "Central diabetes insipidus: a complication of ventriculoperitoneal shunt malfunction during pregnancy."
11/01/2014 - "Although the association between intraventricular hemorrhage and diabetes insipidus has been described in preterm infants, the association between diabetes insipidus and hydrocephalus, and the fact that such central diabetes insipidus could be reversible with the reduction of ventricular size, either because of spontaneous resolution or the placement of ventriculo-peritoneal shunt is first described here in neonates."
02/01/2013 - "Subcutaneous or oral administration of synthetic ADH was effective in central diabetes insipidus treatment during the 19-month follow-up."
02/01/2004 - "The effect of oral administration of desmopressin (DDAVP) solution was investigated in a very low birth weight premature infant with central diabetes insipidus that was associated with grade four germinal matrix hemorrhage. "
10/01/2000 - "In this study, we analyzed plasma lipid and lipoprotein levels before and after treatment with 1-desamino-8-D-arginine vasopressin (DDAVP) in subjects with partial and complete central diabetes insipidus (DI) in order to determine how a shortage and supplement of this hormone affect plasma lipid metabolism. "
09/01/2013 - "Herein, we have report a case of central diabetes insipidus newly diagnosed after kidney transplantation. "
09/01/2013 - "Newly developed central diabetes insipidus following kidney transplantation: a case report."
03/01/2012 - "Unmasking of undiagnosed pre-existing central diabetes insipidus after renal transplantation."
04/01/2001 - "Perioperative management of central diabetes insipidus in kidney transplantation."
09/01/2013 - "The possibility of central diabetes insipidus should be considered in patients presenting with persistent polyuria after kidney transplantation. "